Parallax Volatility Advisers’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,000
| Closed | -$853K | – | 1608 |
|
|
2025
Q4 | $853K | Hold |
10,000
| – | – | ﹤0.01% | 1144 |
|
|
2025
Q3 | $778K | Hold |
10,000
| – | – | ﹤0.01% | 1169 |
|
|
2025
Q2 | $782K | Sell |
10,000
-15,000
| -60% | -$1.12M | ﹤0.01% | 1112 |
|
|
2025
Q1 | $1.81M | Sell |
25,000
-162,900
| -87% | -$11.7M | ﹤0.01% | 894 |
|
|
2024
Q4 | $13.9M | Sell |
187,900
-115,600
| -38% | -$8.09M | 0.03% | 456 |
|
|
2024
Q3 | $20M | Buy |
303,500
+302,800
| +43,257% | +$22M | 0.04% | 338 |
|
|
2024
Q2 | $64.7K | Sell |
700
-69,500
| -99% | -$6.15M | ﹤0.01% | 1738 |
|
|
2024
Q1 | $6.71M | Buy |
70,200
+17,700
| +34% | +$1.49M | 0.02% | 626 |
|
|
2023
Q4 | $4M | Sell |
52,500
-57,200
| -52% | -$3.98M | 0.01% | 907 |
|
|
2023
Q3 | $7.6M | Buy |
109,700
+48,300
| +79% | +$3.88M | 0.02% | 613 |
|
|
2023
Q2 | $5.79M | Sell |
61,400
-98,300
| -62% | -$8.54M | 0.01% | 725 |
|
|
2023
Q1 | $13.2M | Buy |
159,700
+131,600
| +468% | +$10.3M | 0.03% | 489 |
|
|
2022
Q4 | $2.1M | Sell |
28,100
-18,300
| -39% | -$1.41M | ﹤0.01% | 1381 |
|
|
2022
Q3 | $3.83M | Buy |
46,400
+45,500
| +5,056% | +$4.38M | 0.01% | 1128 |
|
|
2022
Q2 | $86K | Sell |
900
-29,400
| -97% | -$3.04M | ﹤0.01% | 2379 |
|
|
2022
Q1 | $3.57M | Buy |
+30,300
| New | +$3.4M | ﹤0.01% | 1125 |
|
|
2020
Q4 | – | Sell |
-115,400
| Closed | -$9.21M | – | 2922 |
|
|
2020
Q3 | $9.21M | Buy |
115,400
+68,600
| +147% | +$5.35M | 0.01% | 1036 |
|
|
2020
Q2 | $3.23M | Sell |
46,800
-30,900
| -40% | -$2.2M | ﹤0.01% | 1265 |
|
|
2020
Q1 | $4.89M | Buy |
77,700
+75,000
| +2,778% | +$5.41M | 0.01% | 873 |
|
|
2019
Q4 | $210K | Buy |
+2,700
| New | +$211K | ﹤0.01% | 1997 |
|
|
2019
Q2 | – | Sell |
-420,000
| Closed | -$26.8M | – | 2850 |
|
|
2019
Q1 | $26.8M | Buy |
+420,000
| New | +$24M | 0.03% | 263 |
|
|
2017
Q3 | – | Sell |
-41,700
| Closed | -$1.64M | – | 2369 |
|
|
2017
Q2 | $1.64M | Buy |
+41,700
| New | +$1.52M | ﹤0.01% | 900 |
|
|
2017
Q1 | – | Sell |
-600
| Closed | -$19K | – | 3803 |
|
|
2016
Q4 | $19K | Hold |
600
| – | – | ﹤0.01% | 2692 |
|
|
2016
Q3 | $24K | Hold |
600
| – | – | ﹤0.01% | 2545 |
|
|
2016
Q2 | $20K | Sell |
600
-74,400
| -99% | -$2.55M | ﹤0.01% | 2313 |
|
|
2016
Q1 | $2.21M | Buy |
+75,000
| New | +$2.07M | ﹤0.01% | 875 |
|
|
2014
Q1 | – | Sell |
-75,000
| Closed | -$822K | – | 3441 |
|
|
2013
Q4 | $822K | Buy |
+75,000
| New | +$845K | ﹤0.01% | 906 |
|
Other funds holding EW
VCM
VPM
Parallax Volatility Advisers's EW Position: Q1 2025 in Review
Parallax Volatility Advisers sold out of Edwards Lifesciences (EW) in Q1 2025, closing a stake of 8 shares — an estimated $573 sold.
Parallax Volatility Advisers first reported a position in EW in Q4 2014 and held it in 17 quarters. The position peaked at $23.6M in Q1 2019. 1,205 funds tracked by Wall St. Rank hold EW as of Q1 2025.
- Parallax Volatility Advisers reported no remaining Edwards Lifesciences position as of Q1 2025 after selling out during the quarter.
- Parallax Volatility Advisers sold 8 Edwards Lifesciences shares in Q1 2025, an estimated $573.
- Parallax Volatility Advisers first reported a position in Edwards Lifesciences in Q4 2014 and held it in 17 quarters.
- Parallax Volatility Advisers's Edwards Lifesciences position peaked at $23.6M in Q1 2019.
- 1,205 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2025.
Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.